23andMe Lays Off 40% of Staff, Shuts Drug Development Business

HS 11/11/2024
Advertisements




The genetics company is closing a unit that was once seen as core to its future.



Source link

More Stories

Europe wants to rebalance trade with Beijing, but can't quit Chinese air conditioners

HS 01/07/2026

World Cup could boost the June jobs report by 40,000, Goldman estimates

HS 01/07/2026

Automakers report mixed U.S. sales results as hybrid vehicles drive growth

HS 01/07/2026

You may have missed

Top stocks to buy today: Stock recommendations for July 2, 2026 – check list

HS 01/07/2026

Europe wants to rebalance trade with Beijing, but can't quit Chinese air conditioners

HS 01/07/2026

Samsung Electronics, SK Hynix shares tumble over 7% as chip rout spreads from Wall Street

HS 01/07/2026

Jim Cramer says this former Covid market darling is finally investable again

HS 01/07/2026

Scientists build from scratch cells that can grow, feed & reproduce

HS 01/07/2026